Lv1
10 积分 2024-04-06 加入
Accelerating drug discovery, development, and clinical trials by artificial intelligence
3天前
已完结
Development and validation of the eMCI‐CHD tool: A multivariable prediction model for the risk of mild cognitive impairment in patients with coronary heart disease
7天前
已完结
Fish oil supplementation, genetic susceptibility and risk of new-onset hypertension
20天前
已完结
Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study
20天前
已完结
Predicting Long-Term Clinical Outcomes of Patients With Recurrent Pericarditis
25天前
已完结
Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis
26天前
已完结
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations
28天前
已完结
A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia
1个月前
已完结
A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia
1个月前
已关闭
Updated Results from a Phase I/II Study of the Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with FLT3-Mutated Acute Myeloid Leukemia
1个月前
已完结
皖公网安备34019202002308
